Novartis Q4 net profit rises to $2.0 billion

Print
Font Size:
Default font size
Larger font size

Posted: Wednesday, January 29, 2014 12:00 am | Updated: 1:08 pm, Mon Mar 31, 2014.

GENEVA (AP) - Swiss drug maker Novartis AG has reported a 2 percent rise in fourth-quarter net profit, helped by delays in generic competition to its blockbuster drugs.

The Basel, Switzerland-based company said Wednesday it had a net profit of $2.029 billion attributable to shareholders in the final three months of 2013, up from a restated $1.985 billion in the same period the previous year.

Chief Executive Joseph Jimenez said Novartis delivered a strong performance in 2013, growing both net sales and core operating income in constant currencies while absorbing patent expirations.

Full-year net profit fell 1 percent to $9.175 billion attributable to shareholders, down from $9.27 billion in 2012.

The company confirmed its outlook for 2014 sales growth is in the low to mid-single digits.

© 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


loading...

SPOTLIGHT »

Inside Business
To submit an announcement for "Inside Business", click here. For questions call (402) 444-1371 or e-mail announcements@owh.com.

World-Herald Alerts

Want to get World-Herald stories sent directly to your home or work computer? Sign up for Omaha.com's News Alerts and you will receive e-mails with the day's top stories.